Biosimilar Newsletter Archive

  1. 08.30.22 -- You're One Partner Away From Bringing Your Biotherapy To Life 8/30/2022

    08/30/22 Biosimilar Development Newsletter

  2. 08.25.22 -- What's The Environmental Impact Of Biopharma Continuous Manufacturing? 8/25/2022
    08/25/22 Biosimilar Development Newsletter
  3. 08.18.22 -- The Near Future Of Regulatory Info Management In EU 8/18/2022
    08/18/22 Biosimilar Development Newsletter
  4. 08.16.22 -- Assessing Risk And Reducing Complexity For Drug Delivery 8/16/2022

    08/16/22 Biosimilar Development Newsletter

  5. 08.11.22 -- Inside Gamma Delta T Cells, Innate Immunity & Mouse Models, and more podcast episodes! 8/11/2022
    08/11/22 Biosimilar Development Newsletter
  6. 08.11.22 -- FDA Approves First Interchangeable Lucentis Biosimilar 8/11/2022
    08/11/22 Biosimilar Development Newsletter
  7. 08.10.22 -- The Value Of SPR 8/10/2022

    08/10/22 Biosimilar Development Newsletter

  8. 08.04.22 -- Strategic Outsourcing Demand: Selecting A CDMO 8/4/2022

    08/04/22 Biosimilar Development Newsletter

  9. 08.04.22 -- FDA, EMA Accept MS Biosimilar Applications 8/4/2022
    08/04/22 Biosimilar Development Newsletter
  10. 07.28.22 -- The Need For Creative Funding For Life Sciences 7/28/2022
    07/28/22 Biosimilar Development Newsletter